24 results on '"Stirling, David A."'
Search Results
2. Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice
3. Discovering cellular programs of intrinsic and extrinsic drivers of metabolic traits using LipocyteProfiler
4. Immune modulatory therapies for spinal cord injury – Past, present and future
5. Targeting MMPs in Acute and Chronic Neurological Conditions
6. Building organizational integrity
7. Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1
8. Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis
9. Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
10. The perinatal and postnatal toxicity of d-methylphenidate and d, l-methylphenidate in rats
11. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
12. Bioavailable Dual-Protein Degraders of CK1α and Transcriptional Kinase CDK9 As Potential Therapeutics for Hematological Malignancies
13. Targeting AML: The Development of Two Functionally and Mechanistically Distinct Classes of Cereblon-Mediated Protein Homeostatic Modulators
14. Direct Inhibitory Effects of Lenalidomide on the Proliferation and VEGF Production of Non-Hodgkin Lymphoma Cells Are Associated with Increased SPARC Expression
15. Lenalidomide Displays Direct Anti-Non-Hodgkin's Lymphoma (NHL) Cell Activity in Association with Enhanced SPARC Expression but Independent of Its Ability to Strongly Inhibit NHL Cell VEGF Production In Vitro.
16. Cathepsin G, a Potent Platelet Aggregation Activator, Is Upregulated in Multiple Myeloma Patients during Treatment with Lenalidomide (Revlimid).
17. Lenalidomide Enhancement of NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity (ADCC) Is Mediated by Granzyme B and FasL and Is Associated with Modification of SHIP-1, PLC-g2 and pERK and Enhanced Chemokine Production.
18. Lenalidomide Displays Anti-Proliferative Activity and Combination Effects with Chemotherapeutic Agents Against a Burkitt's Lymphoma Cell Line.
19. Lenalidomide Strongly Enhances Natural Killer (NK) Cell Mediated Antibody-Dependent Cellular Cytotoxicity (ADCC) of Rituximab Treated Non-Hodkin's Lymphoma Cell Lines In Vitro.
20. Thalidomide Derivative CC-4047 Inhibits Osteoclast Formation by down Regulation of PU.1.
21. Effect of Thalidomide and Revlimid on the Gene Expression That Reveals Molecular Circuitries Involved in T Cell Co-Activation.
22. Combination of the mTOR Inhibitor Rapamycin and Revlimid™ (CC-5013) Has Synergistic Activity in Multiple Myeloma (MM).
23. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
24. The reliability of three sagittal reference planes in the assessment of Class II treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.